NDC 0409-5082 – Tazicef

Ceftazidime 1 g/1 · Injection, Powder, For Solution · Intramuscular, Intravenous

Human Prescription Drug

Product NDC0409-5082

Product details

Brand name
Tazicef
Generic name
Ceftazidime
Labeler
Hospira, Inc.
Dosage form
Injection, Powder, For Solution
Route
Intramuscular, Intravenous
Marketing category
ANDA · ANDA062662
Marketed since
November 2, 2005
Listing expires
December 31, 2027
Pharmacologic class
Cephalosporin Antibacterial

Active ingredients

Uses, dosage, side effects and warnings for Tazicef →

Package NDC codes (2)

Package NDCDescriptionSince
0409-5082-1010 VIAL, SINGLE-DOSE in 1 CARTON (0409-5082-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0409-5082-11)May 5, 2026
0409-5082-1625 VIAL, SINGLE-DOSE in 1 CARTON (0409-5082-16) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0409-5082-11)Nov 2, 2005

Other Tazicef products